Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suppressive Acyclovir on Sexual Behavior in HSV-2
NCT00495716Phase 4Terminated
- Sponsor
- University of Washington
- Start
- Jan 2008
- Primary completion
- Jun 2010
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of aciclovir in genital herpes, sponsored by University of Washington. Primary endpoint: Effect of Suppressive Antiviral Therapy on Sexual Behavior at 1 year. Started Jan 2008; status: terminated.
02
Drugs
aciclovir
03
Conditions
genital herpes
Beyond the preview
Go deeper on NCT00495716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00495716.